| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $93.33M | $115.95M | $131.19M | $125.62M | $72.81M |
| R&D | $68.61M | $86.74M | $98.04M | $94.54M | $54.39M |
| SG&A | $24.72M | $29.21M | $33.16M | $31.08M | $18.41M |
| Operating Income | -$93.33M | -$115.95M | -$131.19M | -$125.62M | -$72.81M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$90.60M | -$111.13M | -$124.08M | -$123.67M | -$72.72M |
| EPS (basic) | -0.5900 | -1.3100 | -1.6800 | -2.7600 | -4.1000 |
| EPS (diluted) | -0.5900 | -1.3100 | -1.6800 | -2.7600 | -4.1000 |
| Shares (diluted) | $152.97M | $84.82M | $73.79M | $44.82M | $17.73M |